cobas® pro i 601 analyzer
Enter a new dimension in mass spectrometry
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
With the cobas® Mass Spec solution, which includes the cobas® i 601 analyzer and the Ionify® reagents line, you can step away from tedious and complex manual mass spectrometry workflows and experience the simplicity and convenience of a streamlined end-to-end solution.
Faster results less complexity with Roche cobas mass spectrometry
Bringing mass spectrometry into routine clinical testing has long been a challenge, limiting access to one of the most selective and sensitive analytical technologies available. Discover how the cobas® pro i 601 analyzer, designed for routine use by today's clinical laboratory staff and to measure the most clinically relevant sample types, is helping change that. By reducing turnaround times and hands-on work, the solution is helping laboratories expand access to high-quality testing. Donald Mason, Senior Marketing Manager for Mass Spectrometry at Roche Diagnostics, shares how this shift could bring the benefits of mass spectrometry to more laboratories, clinicians, and patients.
This interview was recorded at ADLM 2026, Anaheim, California.
Automated LC-MS/MS brings clinical mass spectrometry closer to routine testing
Roche’s Donald Mason explains how automation, standardization, and core-lab integration could help clinical laboratories expand access to mass spectrometry-based testing
Labcorp collaborates with Roche to bring fully automated mass spec to U.S. clinical labs
First U.S. commercial agreement delivers next-generation technology for faster, more accurate diagnostics
Roche expands automated mass spectrometry menu
The fully automated solution replaces labor-intensive manual workflows, reducing turnaround times and supporting faster, standardized, high-quality care
Ionify 25-Hydroxy Vitamin D total test achieves CLIA ‘Moderate Complexity’ categorization
Roche's achievement marks an important step in broadening the clinical utility of mass spectrometry testing across routine labs
Clinical Diagnostics Scientists’ Choice Awards winners announced at ADLM 2025
Roche Diagnostics, Illumina, and Siemens Healthineers among those recognized
